FDA rescinds Emergency Use Authorization of Eli Lilly’s ‘bamlanivimab’ monoclonal antibody treatment
WHITE OAK, MD – JULY 20: A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. (Photo by Sarah Silbiger/Getty Images) OAN NewsroomUPDATED 6:20 PM PT – Saturday, April 17, 2021 The FDA has rescinded its Emergency Use Authorization of Eli Lilly’s ‘bamlanivimab,’…